FDA delays decision on blood thinner
Tuesday, June 24, 2008 - 22:49
in Health & Medicine
INDIANAPOLIS, June 24 (UPI) -- Eli Lilly and Co. says the U.S. Food and Drug Administration has extended the review period for the experimental blood thinner prasugrel.